Page last updated: 2024-08-26

cilastatin and Peritoneal Carcinomatosis

cilastatin has been researched along with Peritoneal Carcinomatosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Al Duhailib, Z; Amin, T; Hakeam, HA; Salahuddin, N	1

Trials

1 trial(s) available for cilastatin and Peritoneal Carcinomatosis

Article	Year
Impact of tigecycline versus imipenem-cilastatin on fibrinogen levels following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): a randomized-controlled study. Journal of chemotherapy (Florence, Italy), 2018, Volume: 30, Issue:4 Topics: Adult; Aged; Anti-Bacterial Agents; Cilastatin; Cytoreduction Surgical Procedures; Drug Therapy, Combination; Fibrinogen; Humans; Hyperthermia, Induced; Imipenem; Male; Middle Aged; Peritoneal Neoplasms; Tigecycline; Treatment Outcome	2018

Article

Year

Impact of tigecycline versus imipenem-cilastatin on fibrinogen levels following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): a randomized-controlled study.

Journal of chemotherapy (Florence, Italy), 2018, Volume: 30, Issue:4

Topics: Adult; Aged; Anti-Bacterial Agents; Cilastatin; Cytoreduction Surgical Procedures; Drug Therapy, Combination; Fibrinogen; Humans; Hyperthermia, Induced; Imipenem; Male; Middle Aged; Peritoneal Neoplasms; Tigecycline; Treatment Outcome

2018